Matthew During

Affiliations: 
Univ Auckland, Auckland, Auckland, New Zealand 
Google:
"Matthew During"
Mean distance: 14.07 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Green TN, Hamilton JR, Morel-Kopp MC, et al. (2017) Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis. Platelets. 1-13
Carruthers KH, Metzger G, Choi E, et al. (2016) A Therapeutic Role for Survivin in Mitigating the Harmful Effects of Ionizing Radiation. Sarcoma. 2016: 1830849
Kamal T, Green TN, Morel-Kopp MC, et al. (2015) Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation. Cellular Signalling
During MJ, Liu X, Huang W, et al. (2015) Adipose VEGF Links the White-to-Brown Fat Switch With Environmental, Genetic, and Pharmacological Stimuli in Male Mice. Endocrinology. 156: 2059-73
Charbonnier-Beaupel F, Malerbi M, Alcacer C, et al. (2015) Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 96-111
Lin EJ, Sun M, Choi EY, et al. (2015) Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrinology. 51: 318-30
Sun M, Choi EY, Magee DJ, et al. (2014) Metabolic Effects of Social Isolation in Adult C57BL/6 Mice. International Scholarly Research Notices. 2014: 690950
Liu X, Magee D, Wang C, et al. (2014) Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype. Molecular Therapy. Methods & Clinical Development. 1
Carruthers KH, Metzger G, During MJ, et al. (2014) Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models. Cancer Gene Therapy. 21: 434-40
Young D, Fong DM, Lawlor PA, et al. (2014) Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy. Gene Therapy. 21: 1029-40
See more...